Navigation Links
Stray Breast Tumor Cells in Early Chemo Could Be Bad Sign
Date:12/12/2010

here's not a very clear correlation between actually watching the tumor shrink and the number of tumor cells," confirmed Dr. Jay Brooks, chief of hematology/oncology at Ochsner Health System in Baton Rouge, La.

And it's far from clear that this simple blood test would be a good replacement for imaging to track the progress of the cancer, he added.

Nor do CTCs tell you which treatment may be best, like certain other markers, including HER2/neu and estrogen-receptor status, added Armstrong, although he said it might indicate the need for a more aggressive approach.

Still, Armstrong said, "these CTCs are likely to become very important because they're not just a protein. They're the actual cancer cell, so if you can isolate them and measure things that have gone wrong inside the cancer cell, you could eventually use them to guide therapy for an individual. [And] you could monitor it over time especially to assess response to treatment and modify treatment [if necessary]. Cancer cells mutate and can develop abnormalities that can be an Achilles' heel for drugs. Without that information, it's very hard to guide therapy."

Other studies being presented at the symposium confirm the potential importance of CTC levels in predicting the odds for a recurrence, or a patient's general prognosis after treatment.

One report, from German researchers, found that the presence of only a few CTCs in the blood -- this time, involving early-stage patients -- roughly doubled the risk for a recurrence and death. Five or more of the tumor cells increased the chances of a relapse by 400 percent and death by 300 percent.

A study from scientists at the M.D. Anderson Cancer Center at the University of Texas found that metastatic breast cancer patients who had both chemotherapy and transplants of their own stem cells and had CTCs in their blood also tended to fare badly.

The stem cells may be responsible by carrying CTCs from the bone marrow into the b
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Higher co-payments increase chance of early discontinuation of breast cancer therapy
2. Depression drug may relieve pain from breast cancer treatment, U-M study finds
3. Novel imaging technique may reduce lymphedema in breast cancer patients
4. Phase III efficacy data on bevacizumab plus chemotherapy in early breast cancer to be presented
5. Circulating tumor cells predicted recurrence, death in patients with early-stage breast cancer
6. High CTC levels predicted poor outcome in metastatic breast cancer
7. CTCs predict poor outcome from blood stem cell transplantation therapy for metastatic breast cancer
8. Poor breast cancer prognosis associated with presence of circulating tumor, cancer stem cells
9. Trio of drugs may combat triple negative breast cancer
10. Simple fingertip test may identify breast cancer patients at risk for carpal tunnel syndrome
11. FDA Weighs In as Sharing of Breast Milk Booms
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Stray Breast Tumor Cells in Early Chemo Could Be Bad Sign
(Date:9/30/2014)... Michigan are pleased to announce an agreement to publish ... Endocrinology , which is now open for submissions and ... , The journal is led by Editor-in-Chief, Meng ... Metabolism, Endocrinology, and Diabetes, at the University of Michigan, ... international Editorial Board. , Clinical Diabetes and ...
(Date:9/30/2014)... cells cannot multiply and cardiac muscles contain few ... itself after a heart attack. Now Tel Aviv ... standard in cardiac tissue engineering. , Dr. Tal ... TAU,s Department of Biotechnology, Department of Materials Science ... have been developing sophisticated micro- and nanotechnological tools ...
(Date:9/30/2014)... NY Four scientists at Cold Spring Harbor Laboratory ... under two new CSHL grants announced in Washington today. ... by the National Institutes of Health (NIH), totaling $46 ... initial funding for the BRAIN Initiative. ... was launched by the President in the spring of ...
(Date:9/30/2014)... A new report launched today by the ... Study on Ageing) conducted by academics from the ... Ireland, has highlighted the serious, complex and unique ... population. , The IDS-TILDA study is the first ... only one in the world with the ability ...
(Date:9/30/2014)... SIMpalm, the top iPhone app development ... great social networking music sharing experience. Lyricz LLC officially ... and iPod touch®. The App allows users to take ... pre-populated ITunes account. This app also gives users the ... photo of their choice to the snippet of selected ...
Breaking Medicine News(10 mins):Health News:BioMed Central to publish open access journal in collaboration with the University of Michigan 2Health News:A heartbeat away? Hybrid 'patch' could replace transplants 2Health News:4 Cold Spring Harbor Laboratory scientists will contribute to President Obama's BRAIN Initiative under new NIH grants 2Health News:4 Cold Spring Harbor Laboratory scientists will contribute to President Obama's BRAIN Initiative under new NIH grants 3Health News:Longitudinal report shows challenging reality of ageing with an intellectual disability 2Health News:Longitudinal report shows challenging reality of ageing with an intellectual disability 3Health News:Longitudinal report shows challenging reality of ageing with an intellectual disability 4Health News:LYRICZ App for iPhone®, Helps You Share Images with Music to Inspire and Influence 2
... chronically ill Medicaid patients designed to provide care ... Jan. 27 Chronically ill members ... Health Insurance plans (CHIP) in Philadelphia are now ... homes, thanks to an innovative new partnership with ...
... A study by healthcare market research firm Manhattan Research ... support for continuing medical education (CME) funding. The results ... in the medical community about the role of commercial ... positions of those who actually use continuing medical education, ...
... thinner, Munro & Associates steps up for their customersTROY, ... and great for our customers," says Sandy Munro, Founder ... deliver 21 years worth of experience more efficiently and ... in today,s climate could spell disaster. No company can ...
... in fruit flies has led researchers to a sensitive and ... common type of kidney cancer. In the journal Science ... the University of Chicago shows that the biomarker known as ... cell carcinomas but not by normal kidney tissue. , Physicians ...
... state, construct prison health care centers throughout California.LOS ANGELES, ... this week to prevent a federal judge and his ... treasury for the sole purpose of reconstructing the state,s ... opposes the proposal to construct seven new prison facilities, ...
... Ages Two Years and Older , FT. WASHINGTON, Pa., ... Inc., today announced the availability of Children,s ZYRTEC(R) Allergy ... flavor product used to treat perennial and seasonal allergic ... ages two years and older. Children,s ZYRTEC(R) Allergy ...
Cached Medicine News:Health News:Physician Home Visits Centerpiece of New AmeriChoice and INSPIRIS Partnership in Philadelphia 2Health News:Physician Home Visits Centerpiece of New AmeriChoice and INSPIRIS Partnership in Philadelphia 3Health News:Manhattan Research Survey Finds That Physicians Overwhelmingly Support Commercially-Funded Continuing Medical Education 2Health News:Manhattan Research Survey Finds That Physicians Overwhelmingly Support Commercially-Funded Continuing Medical Education 3Health News:Survival Favors the Prepared 2Health News:Roadkill study could speed detection of kidney cancer 2Health News:Ventura County Taxpayers' Group Files Suit to Stop State-of-the-Art Hospitals for Incarcerated Felons 2Health News:Children's Sugar-Free, Dye-Free ZYRTEC(R) Allergy Syrup Now Available 2Health News:Children's Sugar-Free, Dye-Free ZYRTEC(R) Allergy Syrup Now Available 3
(Date:9/30/2014)... 30, 2014 Summary This report ... pharmaceutical companies regarding their Information & Communications Technology ... companies currently allocate their ICT budgets across the ... IT services, communications, and consulting. Key ... companies highlights that X% of respondents anticipate an ...
(Date:9/30/2014)... Investor-Edge has initiated coverage on the following ... Zentaris Inc. (NASDAQ: AEZS ), OPKO Health ... (NYSE MKT: NAVB), and Exact Sciences Corporation (NASDAQ: EXAS). ... at: http://investor-edge.com/register . On Monday, September ... 0.14%, the Dow Jones Industrial Average finished the day ...
(Date:9/30/2014)... 2014  Come fall, many children, teenagers, and even ... want to be for Halloween. And, a number of ... contact lenses bought without a prescription. Halloween, ... purchase and wear contact lenses without a prescription. According ... consumer survey, 17 percent of Americans have worn ...
Breaking Medicine Technology:ICT investment trends in pharmaceuticals - Enterprise ICT spending patterns through to the end of 2015 2ICT investment trends in pharmaceuticals - Enterprise ICT spending patterns through to the end of 2015 3Watch List for Biotech Equities - Immunomedics, Aeterna Zentaris, OPKO Health, Navidea Biopharma, and Exact Sciences 2Watch List for Biotech Equities - Immunomedics, Aeterna Zentaris, OPKO Health, Navidea Biopharma, and Exact Sciences 3Watch List for Biotech Equities - Immunomedics, Aeterna Zentaris, OPKO Health, Navidea Biopharma, and Exact Sciences 4Watch List for Biotech Equities - Immunomedics, Aeterna Zentaris, OPKO Health, Navidea Biopharma, and Exact Sciences 5The Spooky Truth: What You Need To Know About Contact Lens Hygiene 2The Spooky Truth: What You Need To Know About Contact Lens Hygiene 3
... SAN DIEGO, Sept. 26, 2011 Elevation Pharmaceuticals, Inc., ... aerosol therapies for patients with respiratory diseases, today announced ... and Chief Business Officer and Pravin Soni, PhD, as ... created positions. The company also announced that it drew ...
... 26, 2011 Clermont Pharmaceuticals, Inc., a ... positive results from a phase III trial ... latanoprost was compared to Xalatan® (latanoprost ophthalmic ... glaucoma.  Non-preserved latanoprost achieved the primary efficacy ...
Cached Medicine Technology:Elevation Pharmaceuticals Strengthens Management Team with Appointment of Executives 2Elevation Pharmaceuticals Strengthens Management Team with Appointment of Executives 3Clermont Pharmaceuticals Reports Positive Phase III Results for Drug to Treat Glaucoma 2
The Spex SkinSkan is the only in-vivo, fibre-optic spectrofluorometer designed specifically for skin-fluorescence measurements. It is also ideal for many remote sensing steady-state fluorescence appl...
The unique RF-1501 optical design provides exceptional sensitivity in an incredibly compact instrument....
... Quantitation of DNA, RNA, Or Fluorescent Tags. Accurate ... is critical to life science research. The RF-Mini ... measure quantities as small as 1ng/ml of DNA ... of excitation and emission filters, the RF-Mini 150 ...
The Fluoroskan Ascent FL is equipped with both fluorometric and luminometric measurement technologies, providing a full coverage for fluorometric, glow and flash luminometric applications even in the...
Medicine Products: